The Conversation (0)
Abattis Bioceuticals provided shareholders with an update into their official rebranding as a provider of downstream cannabis solutions for LPs.
Abattis Bioceuticals (CSE:ATT; OTC:ATTBF) provided shareholders with an update into their official rebranding as a provider of downstream cannabis solutions for licensed producers (LPs).
As quoted in the press release:
The Company’s new focus on downstream solutions reflects several of its recent acquisitions and the success of its fully integrated services offerings. These offerings now include biomass production, federally-licensed research and development and analytical services, regulatory services, logistics support for the manufacture, sale, distribution and marketing of cannabinoid-containing finished products and cannabinoid delivery products and blockchain-based peer-to-peer payment technologies.
“We intend for the rebranding to consolidate our recent acquisitions and pave the way for exciting new partnerships in the future,” stated Rob Abenante, President and CEO of Abattis. “For example, our recent acquisition of Gabriola Green Farms will round out our supply chain, providing us and our partners with integrated services spanning from biomass production to the manufacture of high-end cannabis extracts,” added Mr. Abenante.
“While continuing to develop our in-house nanotechnology delivery platforms, we hope to support our partners in multiple aspects of their businesses, from helping them increase manufacturing and distribution capacity to, in the case of established brands, guiding their entry into the cannabis space. Our suite of integrated services will also address our partners’ future needs, providing comfort that they will be able to adapt once legalization arrives this summer,” further stated Mr. Abenante.
Click here to read the full press release.
Source: globenewswire.com
